Mucinex D Tablet, Extended Release
Product Images NDC 63824-041

1 FDA label image from Reckitt Benckiser Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Mucinex D (NDC 63824-041). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Reckitt Benckiser Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (24 Tablet Blister Pack Carton)

Principal Display Panel (24 Tablet Blister Pack Carton)
Mucinex D Maximum Strength extended-release bi-layer tablets with 1200 mg guaifenesin and 120 mg pseudoephedrine hydrochloride. The label highlights 12-hour symptom relief, expectorant and nasal decongestant properties, and package count of 24 tablets. Manufactured by Reckitt Benckiser LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.